Efficacy of levosimendan infusion in patients undergoing a left ventricular assist device implant in a propensity score matched analysis of the EUROMACS registry—the Euro LEVO-LVAD study

OBJECTIVES: Early right-sided heart failure (RHF) was seen in 22% of recipients of a left ventricular assist device (LVAD) in the European Registry for Patients with Mechanical Circulatory Support (EUROMACS). However, the optimal treatment of post-LVAD RHF is not well known. Levosimendan has proven...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelshafy, Mahmoud, Caliskan, Kadir, Simpkin, Andrew J, Elkoumy, Ahmed, Kimman, Jesse R, Elsherbini, Hagar, Elzomor, Hesham, de By, Theo M M H, Gollmann-Tepeköylü, Can, Berchtold-Herz, Michael, Loforte, Antonio, Reineke, David, Schoenrath, Felix, Paluszkiewicz, Lech, Gummert, Jan, Mohacsi, Paul, Meyns, Bart, Soliman, Osama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Tx & Mcs
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693438/
https://www.ncbi.nlm.nih.gov/pubmed/36912728
http://dx.doi.org/10.1093/ejcts/ezad095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693438/
https://www.ncbi.nlm.nih.gov/pubmed/36912728
http://dx.doi.org/10.1093/ejcts/ezad095

Ejemplares similares